Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Daiichi Sankyo and AstraZeneca’s
Daiichi Sankyo and AstraZeneca’s Datroway receives approval in China
Pfizer says
Pfizer says it couldn't have warned about tumor risk in Depo-Provera lawsuits
Swedish startup
Swedish startup secures €2.3M seed funding to boost AI monitoring tools for preclinical research
Merck Valuation in Focus
Merck Valuation in Focus After FDA Breakthrough Therapy Designation for Lung Cancer Drug
UK pharma drug price
UK pharma drug price talks break down as industry fails to lower discount rate
Johnson & Johnson
Johnson & Johnson reveals $2 billion update on Fujifilm factory in Holly Springs
Back in the U.S.A
“Back in the U.S.A.”: FDA Launches PreCheck Program to Boost Domestic Drug Manufacturing
Pharmaceuticals’ Modeyso
FDA approves Jazz Pharmaceuticals’ Modeyso as first drug for ultra-rare brain cancer
Santen and RemeGen
Santen and RemeGen sign licence deal for retinal disease injection
Lupin launches Bosentan
Lupin launches Bosentan tablets for oral suspension in US market
AAIC 2025
AAIC 2025 Preclinical Results of Anti-Tau Antibody MK-2214 in Alzheimer Disease
Merck announces EC approval of Ogsiveo for desmoid tumours
The European Commission (EC) has granted marketing authorisation to SpringWorks Therapeutics, a subsidiary of Merck KGaA
54
55
56
57
58
59
60
61
62
